{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:37:34Z","timestamp":1785299854016,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41409-024-02410-3","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:03:25Z","timestamp":1725969805000},"page":"1780-1782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progressive multifocal leukoencephalopathy after CAR-T cell therapy"],"prefix":"10.1038","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9469-6468","authenticated-orcid":false,"given":"Michael","family":"Montoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah J.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Messimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-5945","authenticated-orcid":false,"given":"Reena V.","family":"Jayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetola","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4335-7942","authenticated-orcid":false,"given":"Andrew P.","family":"Jallouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-0604","authenticated-orcid":false,"given":"James","family":"Jerkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-4079","authenticated-orcid":false,"given":"Eden A.","family":"Biltibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-3655","authenticated-orcid":false,"given":"Bhagirathbhai","family":"Dholaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8525-9641","authenticated-orcid":false,"given":"Olalekan","family":"Oluwole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"2410_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.15252\/emmm.201607485","volume":"9","author":"J Hartmann","year":"2017","unstructured":"Hartmann J, Sch\u00fc\u00dfler\u2010Lenz M, Bondanza A, Buchholz CJ. Clinical development of CAR-T cells\u2014challenges and opportunities in translating innovative treatment concepts. EMBO Mol Med. 2017;9:1183\u201397.","journal-title":"EMBO Mol Med"},{"key":"2410_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","volume":"8","author":"D Pavlovic","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M, for the Progressive Multifocal Leukoencephalopathy Consortium. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015;8:255\u201373.","journal-title":"Ther Adv Neurol Disord"},{"key":"2410_CR3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jha2.274","volume":"2","author":"S Mackenzie","year":"2021","unstructured":"Mackenzie S, Shafat M, Roddy H, Hyare H, Neill L, Marzolini MAV, et al. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti\u2010CD19 CAR\u2010T therapy: a case report. eJHaem. 2021;2:848\u201353.","journal-title":"eJHaem"},{"key":"2410_CR4","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.34468","volume":"64","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. 2012;64:3043\u201351.","journal-title":"Arthritis Rheum"},{"key":"2410_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.15274\/NRJ-2014-10087","volume":"27","author":"V Felli","year":"2014","unstructured":"Felli V, Di Sibio A, Anselmi M, Gennarelli A, Sucapane P, Splendiani A, et al. Progressive multifocal leukoencephalopathy following treatment with rituximab in an HIV-negative patient with non-Hodgkin lymphoma: a case report and literature review. Neuroradiol J. 2014;27:657\u201364.","journal-title":"Neuroradiol J"},{"key":"2410_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood.2022017386","volume":"141","author":"A Goldman","year":"2023","unstructured":"Goldman A, Raschi E, Chapman J, Santomasso BD, Pasquini MC, Perales MA, et al. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. Blood. 2023;141:673\u20137.","journal-title":"Blood"},{"key":"2410_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ana.22408","volume":"70","author":"FJ Mateen","year":"2011","unstructured":"Mateen FJ, Muralidharan R, Carone M, Van De Beek D, Harrison DM, Aksamit AJ, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol. 2011;70:305\u201322.","journal-title":"Ann Neurol"},{"key":"2410_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12185-020-02840-x","volume":"112","author":"K Sdrimas","year":"2020","unstructured":"Sdrimas K, Diaz-Paez M, Camargo JF, Lekakis LJ. Progressive multifocal leukoencephalopathy after CAR-T therapy. Int J Hematol. 2020;112:118\u201321.","journal-title":"Int J Hematol"},{"key":"2410_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.14740\/jh903","volume":"10","author":"JT Ahrendsen","year":"2021","unstructured":"Ahrendsen JT, Sehgal K, Sarangi S, Uhlmann EJ, Varma H, Arnason J, et al. Progressive multifocal leukoencephalopathy after chimeric antigen receptor T-cell therapy for recurrent non-Hodgkin lymphoma. J Hematol. 2021;10:212\u20136.","journal-title":"J Hematol"},{"key":"2410_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s13311-020-00848-z","volume":"17","author":"SR Dunham","year":"2020","unstructured":"Dunham SR, Schmidt R, Clifford DB. Treatment of progressive multifocal leukoencephalopathy using immune restoration. Neurotherapeutics. 2020;17:955\u201365.","journal-title":"Neurotherapeutics"},{"key":"2410_CR11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMc1816198","volume":"380","author":"O Walter","year":"2019","unstructured":"Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, et al. Treatment of progressive multifocal leukoencephalopathy with nivolumab. N Engl J Med. 2019;380:1674\u20136.","journal-title":"N Engl J Med"},{"key":"2410_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s13365-020-00899-0","volume":"26","author":"A Holmes","year":"2020","unstructured":"Holmes A, Wellings T, Walsh O, Rowlings P. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab. J Neurovirol. 2020;26:961\u20133.","journal-title":"J Neurovirol"},{"key":"2410_CR13","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","volume":"379","author":"M Muftuoglu","year":"2018","unstructured":"Muftuoglu M, Olson A, Marin D, Ahmed S, Mulanovich V, Tummala S, et al. Allogeneic BK virus\u2013specific T cells for progressive multifocal leukoencephalopathy. N Engl J Med. 2018;379:1443\u201351.","journal-title":"N Engl J Med"},{"key":"2410_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/ejh.13583","volume":"106","author":"A Mian","year":"2021","unstructured":"Mian A, Andrapalliyal N, Weathers AL, Pohlman B, Hill BT. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy. Eur J Haematol. 2021;106:584\u20138. https:\/\/doi.org\/10.1111\/ejh.13583.","journal-title":"Eur J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02410-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T18:02:44Z","timestamp":1733162564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02410-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02410-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BD reports research funding from Gilead\/Kite, BMS, Wugen, Adicet, and Poseida. consultant: Gilead\/Kite, Janssen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}